Ovid Therapeutics Financials - Benzinga

Ovid Therapeutics Inc

OVIDNASDAQ

Trade with Public

Trade with Public

$2.91

0.093.19%

At close: Aug 25, 5:00 PM EST

$2.98

0.0692.37%

After Hours: 5:51 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Ovid Therapeutics Financials

Ovid Therapeutics (OVID) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Ovid Therapeutics Q2 EPS $(0.08) Beats $(0.12) Estimate, Sales $733.000K Beat $30.000K Estimate

Ovid Therapeutics (NASDAQ:OVID) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.12) by 27.27 percent. This is a 33.33 percent decrease over losses of $(0.06) per share

Benzinga Newsdesk

PRO
Ovid Therapeutics Q1 EPS $(0.12) Misses $(0.11) Estimate

Ovid Therapeutics (NASDAQ:OVID) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.11) by 9.09 percent. This is a 14.29 percent increase over losses of $(0.14) per share

Benzinga Newsdesk

Ovid Therapeutics' New Epilepsy Trial Data Ignites Rally

Ovid Therapeutics shares climb after positive epilepsy data, new trial launch, and $60 million funding boost extending runway into 2028.

Vandana Singh

Earnings Scheduled For March 18, 2026

Benzinga Insights

PRO
Ovid Therapeutics Q4 EPS $0.06 Beats $(0.11) Estimate, Sales $718.000K Beat $13.333K Estimate

Ovid Therapeutics (NASDAQ:OVID) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $(0.11) by 152.63 percent. This is a 146.15 percent increase over losses of $(0.13) per share

Benzinga Newsdesk

PRO
Ovid Therapeutics Q3 EPS $(0.17) Misses $(0.15) Estimate, Sales $132.000K Beat $131.429K Estimate

Ovid Therapeutics (NASDAQ:OVID) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.15) by 15.65 percent. This is a 15 percent increase over losses of $(0.20) per share from

Benzinga Newsdesk